Argos Therapeutics, Inc. To Present At Two Upcoming Healthcare Conferences

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DURHAM, N.C., June 11, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that Jeff Abbey, president and chief executive officer, will be presenting at the 2014 Wells Fargo Healthcare Conference on June 17, 2014, at 4:40 p.m. Eastern Time at The InterContinental Hotel in Boston, MA. Mr. Abbey will also participate in a fireside chat at the JMP Securities 2014 Healthcare Conference on June 25, 2014 at 2:30 p.m. Eastern Time at The Westin New York Grand Central Hotel, in New York, NY.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC